Results 111 to 120 of about 43,285 (196)

Outcomes of Non‐Paroxysmal AF Undergoing Ablation Guided by a Novel High‐Density Panoramic Cycle‐Length Mapping System

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Catheter ablation is a current therapeutic approach for atrial fibrillation (AF). However, the efficacy for non‐paroxysmal AF remains suboptimal. Objective We hypothesize that the novel panoramic cycle‐length mapping (CLM) system can guide the pulmonary vein (PV) isolation and additional potential AF drivers.
Ting‐Yung Chang   +10 more
wiley   +1 more source

Amiodarone to Prevent Recurrence of Atrial Fibrillation [PDF]

open access: bronze, 2000
Denis‐Claude Roy   +11 more
openalex   +1 more source

Trends and Outcomes of Anticoagulation for Post‐Operative Atrial Fibrillation After Coronary Artery Bypass Graft

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The benefit of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF) after coronary bypass grafting remains uncertain. The 2023 American Heart Association (AHA) and the American College of Cardiology (ACC) guidelines recommend 60 days of anticoagulation for POAF, whereas management was ...
Daniel S. Cheah   +4 more
wiley   +1 more source

Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation [PDF]

open access: bronze, 2006
Yuehui Yin   +12 more
openalex   +1 more source

Pulse Field Ablation for Persistent Atrial Fibrillation: Targeting the Persistent Superior Vena Cava

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Persistent left superior vena cava (PLSVC) is a rare vascular anomaly that can act as a trigger for atrial fibrillation (AF). Thermal ablation in this region carries a notable risk. Pulse field ablation (PFA), a non‐thermal modality, offers a safer alternative.
Sara Vázquez‐Calvo   +3 more
wiley   +1 more source

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

open access: yesExperimental Physiology, EarlyView.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber   +10 more
wiley   +1 more source

In silico predictions of action potential propagation in doxorubicin cardiotoxicity: A parametric study using preclinical 3D magnetic resonance imaging‐based fibrotic left ventricle models

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic overview of the study's methodology and key findings. In a preclinical swine model, doxorubicin administration induced cardiotoxicity, characterized by diffuse fibrotic remodelling and altered electrical function, as assessed by magnetic resonance (MR) imaging and electrophysiological mapping.
Javier Villar‐Valero   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy